Skip to main content
JW LIFESCIENCE CORPORATION logo

JW LIFESCIENCE CORPORATION — Investor Relations & Filings

Ticker · 234080 ISIN · KR7234080000 KO Manufacturing
Open in API
Filings indexed 190 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 234080

About JW LIFESCIENCE CORPORATION

https://www.jw-lifescience.co.kr/lifesc…

JW LIFESCIENCE CORPORATION is a specialized manufacturer focused on the development and production of infusion solutions. The company's product portfolio includes a comprehensive range of intravenous (IV) fluids, from basic solutions to advanced nutrient infusions containing essential components such as amino acids, lipids, proteins, vitamins, and minerals. A key area of innovation is the development of high-value-added products, including multi-chambered infusion solutions. The company operates world-class manufacturing facilities and maintains dedicated research and development centers to support its commitment to producing high-quality medical fluids for patient treatment.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서” (Quarterly Report) for the 33rd fiscal period covering January 1 to March 31, 2026, filed to the Financial Services Commission and Korea Exchange. It contains full financial statements (consolidated and standalone), management discussion & analysis, audit opinion, corporate governance details, and other quarterly disclosures. This matches the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-15 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 88% confidence The document is a statutory preliminary earnings announcement (‘영업(잠정)실적(공정공시)’) by JW생명과학 detailing Q1 2026 provisional sales, operating profit, pre-tax profit, and net income compared to prior periods. It contains key quarterly financial metrics in a tabular summary and notes that figures are unaudited and subject to change. This matches the definition of an Earnings Release (initial announcement of quarterly financial results). Q1 2026
2026-05-13 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 95% confidence The document is a “주식등의 대량보유상황보고서(약식)” detailing changes in an investor’s holdings of a listed company, including prior and current share counts, transaction details, and reasons for changes. This matches the definition of a Major Shareholding Notification (MRQ).
2026-04-07 Korean
기업가치제고계획(자율공시)
Regulatory Filings Classification · 70% confidence The document is a voluntary ‘기업가치 제고 계획’ (corporate value enhancement plan) outlining future dividend policy targets and related matters. It is not an actual dividend notice with fixed amounts (hence not DIV), nor a financing or share issuance update (CAP/SHA), nor a governance or board change document. It is a general regulatory announcement (자율공시) providing forward-looking plan details, fitting the fallback Regulatory Filings category.
2026-03-27 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is titled as the results of the regular shareholders’ meeting (정기주주총회결과) and lists each agenda item, voting outcomes (찬성율, 반대율), and details of approvals (e.g., financial statements approval, dividend resolution, election of directors). This matches the definition of “Declaration of Voting Results & Voting Rights Announcements” (DVA).
2026-03-26 Korean
사업보고서 (2025.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Business Report' (사업보고서) for JW Life Science, covering the fiscal year 2025 (Jan 1, 2025 to Dec 31, 2025). It contains detailed sections on company overview, business operations, financial statements, management analysis, and governance, which aligns with the definition of an Annual Report (10-K). FY 2025
2026-03-18 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.